Skip to main content
PLOS One logoLink to PLOS One
. 2021 Sep 16;16(9):e0257453. doi: 10.1371/journal.pone.0257453

Accuracy of perceived glaucoma risk by patients in a clinical setting

Chiun-Ho Hou 1,2,3,4, Jiahn-Shing Lee 1,4, Ken-Kuo Lin 1,4, Laura Liu 1,4, Yung-Sung Lee 1,4, Christy Pu 2,*
Editor: Timo Eppig5
PMCID: PMC8445404  PMID: 34529708

Abstract

Objective

To determine whether patients attending the ophthalmology department underestimate their glaucoma risks.

Method

We conducted a cross-sectional survey with a final study population of 1203 individuals from two medical centers in Taiwan during January 1–June 30, 2019. The “High concern” group was defined as the set of patients who rated themselves as having low risk but who had been rated by physicians as having medium or high risk of developing glaucoma over the next year.

Results

Approximately 12% of the respondents belonged to the “High concern” group. For those with education at the college level or higher, the interaction term was estimated to be 0.294 (95% CI = 0.136–0.634). Marginal effect calculations revealed significant sex-based differences in the effect of knowledge at specific age intervals.

Conclusions

A considerable proportion of patients attending the ophthalmology department underestimate their glaucoma risks. Misjudgment of glaucoma risks can lead to delays in seeking of medical attention. Glaucoma education should be designed according to each patient’s education level and sex, as its effect is not consistent across different education and sex clusters.

Introduction

Late presentation for glaucoma is a major risk factor for blindness [1]. Patients often go blind due to glaucoma without ever having been diagnosed [2], and this problem has not improved over the past 2 decades [3]. The Baltimore Eye survey showed that approximately 50% of the people in the United States with optic nerve damage from primary open-angle glaucoma were unaware that they have the condition [4]. A study conducted on the Hispanic population in the US found that up to 62% of the study subjects with open-angle glaucoma had not been aware of their condition before they were screened; the prevalence of undiagnosed glaucoma increases with age [5].

Improving awareness of symptoms of glaucoma, signs of glaucoma, and knowledge regarding glaucoma, however, does not guarantee prompt diagnosis, because an undiagnosed patient may have high awareness and knowledge of glaucoma, but may not perceive he or she is at glaucoma risk. To initiate a medical event, the patient must first suspect the possibility of a medical condition.

Perceived risk has been studied for other diseases but has rarely been studied in ophthalmology. For other diseases [6], found that a perceived risk of falls is useful in assessing the risk of falls for elderly individuals. Similar studies have been performed on cardiovascular diseases, wherein the perceived risk is positively associated with the actual event [7]. Perceived breast cancer risk has also been found to have mediated the negative effect of pain on distress for post-surgery breast cancer survivors, as well as unaffected women [8].

Despite various studies that have been performed to assess perceived risks, two shortcomings still remain to be addressed. First, no such study has been undertaken for glaucoma. Glaucoma differs from many chronic diseases in that glaucoma often progresses without obvious symptoms, and the progression of the condition often remains unnoticed. Thus, it may not be safe for a patient to compare self-perceived risks with actual events because perceived high risk based on symptoms would lead to late presentation for glaucoma. Second, previous studies on the perceived risk have not evaluated whether such perceptions are valid.

Studies on the role of education level and glaucoma are scarce. Socioeconomic status such as education can affect glaucoma prevalence independent of any hereditary predisposition [9]. A study by Fraser et al. [10] has demonstrated that educational deprivation is a key determinant of late presentation for glaucoma as socioeconomic status influences awareness of the disease and the need for regular eye-sight testing. Hoevenaars et al. [11] found that knowledge of glaucoma and its treatment is positively associated with socioeconomic status. Oh et al. [12] found that the diagnosed prevalence of glaucoma decreased with education. The current study contributes to the literature in two ways. First, we examine patients’ perception of glaucoma and compare with risks evaluated by their ophthalmologists, and second, we evaluate whether the effect of knowledge on glaucoma and education play a role in this risk-evaluation discrepancy.

Methods

We conducted a cross-sectional survey from January 1 to June 30, 2019. The questionnaires were self-administered, in paper form, by patients who visited the department of ophthalmology at two medical centers under one hospital chain in the Northern part of Taiwan (Chang Gung Memorial Hospital). Patients older than or equal to 20, willing to participate, and were able to complete the questionnaire were included. The survey was self-administered at the site, with trained assistants standing ready to answer any questions from the respondent. The questionnaire was developed by the authors (see S1 and S2 Files for the questionnaire). The questionnaire consisted of sections on the demographic and socioeconomic status of the respondents, on knowledge of causes, symptoms, and signs of glaucoma (explained in detail later), and a section on physician ratings. The questionnaire was reviewed by six ophthalmologists and two public health experts. Approximately 15 patients from the pre-test were asked to fill out the questionnaire again upon their next visits for reliability testing. The questionnaire was then modified accordingly. The National Yang Ming University Institutional Review Board (IRB) approved the study (IRB number: YM107106F). Written informed consents were obtained from all participants.

A total of 1203 valid questionnaires were collected. We were not able to calculate an exact response rate because a patient can only participate in the survey once, and hence patients with repeated visits during the study period were excluded if they had already been required to fill out the questionnaire during a previous visit. A response rate that used all patients as the denominator thus would significantly underestimate the response rate.

Self-assessed and physician-assessed risk of glaucoma

The respondent was asked the question “Do you think you are at a risk of developing glaucoma over the next year?” The respondents chose from five responses, namely (1) High risk, (2) Medium risk, (3) Low risk, (4) I have no idea, and (5) I already have glaucoma.

An ophthalmologist evaluated whether he/she considered the respondent to be at a risk of developing glaucoma over the next 1 year based on the same five responses listed previously. We asked the physicians to rate the patient’s risk based on his/her medical examination results (visual field and optical coherent tomography) and the following factors: (1) age over 40 years; (2) family members with glaucoma; (3) high ocular pressure; (4) severe farsightedness or nearsightedness; (5) past ocular injury; (6) long-term steroid medication; (7) has corneas that are thin in the center; (8) thinning of the optic nerve, and (9) diabetes and high blood pressure. The physician was asked to tick on a paper form whether the aforementioned nine conditions were present for the patient and to provide an overall assessment based on these conditions.

We can define the “High concern group” as consisting of patients who rate themselves as having low risk or having no idea of his/her risk, whereas his/her physician would rate him/her as having medium or high risk. For comparison purposes, we also included a question asking the patients to rate their risks for future development of glaucoma compared with other people of similar age.

Education and glaucoma knowledge

Education is self-reported by the respondent and is a categorical variable with the following four categories: (1) Primary school or illiterate; (2) Junior high school; (3) Senior high school, and (4) College and above. A series of questions on glaucoma knowledge were asked. The selection of the knowledge questions was based on standard literature. The answers must be selected from three options; (1) True, (2) False, and (3) Don’t know. These questions were as follows:

  1. Glaucoma can be completely cured

  2. Cataracts can lead to glaucoma

  3. Over-use of the eyes can lead to glaucoma

  4. People with no family history have lower chances of getting glaucoma

  5. Early-stage glaucoma does not have symptoms

  6. In general, an ocular pressure lower than 30 mmHg is considered normal.

We subsequently included a series of questions based on glaucoma symptoms:

  1. Blurred vision

  2. Pain in the eye

  3. Halo around light

  4. Nausea

  5. Headache

Statistical analysis

Because our sample was drawn from a nonprobability sample, we employed the quasirandomization weighting that had been proposed by Valliant [13]. This weighting process estimates pseudo-inclusion probabilities of each individual using variables that are available in both the survey and national representative data set (the reference data set). Because this method required individual data from the reference survey, we used 2013 National Health Insurance (NHI) claims data that included one million randomly selected individuals in Taiwan. The year 2013 was the most up-to-date available year that allowed us to obtain data and to match them to our survey data. For efficient estimation, we randomly selected 50,000 individuals from the data set. The common variables available for our survey and the NHI data were age, sex, and place of residence. Because our survey was not intended to represent the general population (the individuals were patients selected on site), we eliminated individuals who had not visited the ophthalmology department from the reference data set. To test the consistency of this weight assignment, we repeated the weight calculation 10 times with independent random selection of 50,000 individuals and recalculated the weight for each random selection. The overall correlation between each of these 10 calculations was greater than 0.95. To further ensure our weight was not biased due to variation in weighting methods, we executed model-based weighting using sub-population totals from the same reference data set. The correlation of the weights obtained between this method and the pseudo-inclusion probabilities methods still remained greater than 0.95. For a thorough discussion on the significance of weighting and methods of weighting as previously described, please refer to Valliant [13].

For the glaucoma knowledge questions, the proportions of respondents that reported the correct answers were recorded. We then assigned one point for each correct answer, summed the scores, and treated the variable as a continuous variable.

Furthermore, we designed a logistic regression model using a model-building process [14]. First, we conducted an exploratory bivariate analysis to determine relevant variables. These variables were required be scientifically relevant to the outcome variable (risk-evaluation discrepancy). Subsequently, we retained variables with a statistical significance of p < 0.25 based on the bivariate analysis. Wald tests for multiple coefficients were subsequently applied to remove redundant variables to make the model parsimonious. Because our variables of interest were education and knowledge score, we tested interactions between these two variables, as well as interactions for these two variables along with age and sex. Subsequently, we repeated the estimation by removing non-significant interactions. We performed a goodness-of-fit test at each stage to check model fit. A model was not considered fit unless the goodness-of-fit test was passed. The final model was developed using the aforementioned process. Based on the final model, we calculated the marginal effect of the main variables of interest.

Results

Table 1 shows the proportions of responses for each category for patients and physicians. A total of 141 individuals were found to fit the definition of the “High concern” group. Most respondents were not able to evaluate their glaucoma risk (53.45%). Physicians were relatively likely to respond with ‘unable to evaluate’ if the patient was visiting them for the first time. Only 7.15% of the responses from physicians belong to this category; the majority of the responses belong to low risk. In cases when the patients were not able to evaluate their risks but the physician rated them in the low-risk category, the situation was deemed to be of less concern than if the physician had rated them under the high-risk category.

Table 1. Self-rated glaucoma risk and physician-rated glaucoma risk, unweighted.

Responses by patient/physician Self-rated Physician-rated P value
    (1) High risk 22 1.83 39 3.24 <0.0001
    (2) Medium risk 29 2.41 125 10.39
    (3) Low risk 359 29.84 762 63.34
    (4) Have no idea 643 53.45 86 7.15
    (5) Already have glaucoma 150 12.47 191 15.88
Compare with people with your age, do you think you have a higher risk of developing glaucoma?
    (1) Higher 72 5.99
    (2) Same 47 3.91
    (3) Lower 275 22.86
    (4) Have no idea 659 54.78
    (5) Already have glaucoma 150 12.47

Table 2 shows the weighted sample stratified by whether the patients were in the “High concern” group. Age, sex, education, and marital status were not statistically significant between the two groups. Proportions of correct answers to certain knowledge questions were significantly different between the two groups. Family history of glaucoma and habits of glaucoma checkup were dropped during the model-building process. We retained the age variable despite its non-significance at this stage due to its strong scientific relevancy suggested by previous studies. We believed including this one additional variable would not significantly compromise the efficiency of the model, and it would provide useful information.

Table 2. Weighted sample characteristic (n = 1203).

Not in high concern group Row proportion High concern group Row proportion Pearson/Wald test
(n = 1062) (n = 141)
n n p-value
Age (mean, SD) 54.39 (3.2) 53 3.42(52.7) 0.720
Sex (male) 0.978 51 0.022 0.068
Education
    Primary school/illiterate 263 0.960 30 0.040 0.089
    Junior high school 124 0.990 16 0.010
    Senior high school 279 0.969 38 0.031
    College or above 396 0.902 57 0.098
Marital status 0.059
    Never married 169 0.859 21 0.142
    Married/cohabitate 786 0.974 105 0.026
    Widowed/separated 107 0.942 15 0.058
Self-rated financial status
    Surplus 394 0.960 60 0.040 0.302
    Balanced 568 0.926 72 0.075
    Shortage 100 0.985 9 0.015
Glaucoma knowledge by item (correct score)
    1.Glaucoma can be cured 275 0.971 38 0.030 0.278
    2.Cataract can lead to glaucoma 196 0.977 32 0.023
    3.Over use of eyes can lead to glaucoma 110 0.917 11 0.083
    4.People with no family history have lower chances of getting glaucoma 397 0.959 56 0.041
    5.Early-stage glaucoma does not have symptoms 290 0.968 32 0.032 0.385
    6.Generally speaking, ocular pressure lower than 30mmHg is considered normal. 135 0.956 22 0.044 0.692
Glaucoma symptoms
    1.Blurred vision 236 0.984 27 0.016 0.025
    2.Pain in the eye 138 0.980 16 0.020 0.146
    3.Halo around light 115 0.980 13 0.020 0.164
    4.Nausea 73 0.992 6 0.008 0.015
    5.Headache 108 0.988 11 0.012 0.040
Glaucoma Knowledge total score (mean, SD) 1.974(0.4) 0.819 (0.5) 0.079
Total outpatient times during the past 6 months (mean, SD) 1.890(0.2) 1.395(2.3) 0.142
Family history of glaucoma (yes) 64 0.938 12 0.062 0.912
Habit of glaucoma test
    Once per year 41 0.922 6 0.078 0.587
    Once per 0.5 year 82 0.972 10 0.029
    No specific habit 939 0.942 125 0.058

SD = Standard deviation.

Table 3 shows the base model and final model for the logistic regression with dependent = 1 for any respondent in the “High concern” group. Age, sex, education, and marital status were significant predictors in the base model. In this model, knowledge score showed a protective effect. However, in the full model, the estimates for this variable turned non-significant. This shows the significance of adding interaction terms. High levels of education did not exhibit a protective effect; highly educated patients showed relatively high odds of being in the “High concern” group. To assist in the interpretation of the main effect and interaction terms, we calculated the marginal effects of education and sex at each category of age.

Table 3. Logistic regression for factors associated with high risk, weighted.

Base model Full model with interactions
Odds ratio 95%CI P value Odds ratio 95%CI P-value
Total glaucoma knowledge score 0.595 0.387 0.915 0.018 1.706 0.604 4.821 0.313
Age 1.043 1.013 1.074 0.005 1.034 1.003 1.066 0.031
Sex (female) 3.955 1.595 9.808 0.003 4.972 1.567 15.774 0.007
Education
    Primary school/illiterate 1.000
    Junior high school 0.146 0.028 0.776 0.024 0.114 0.025 0.514 0.005
    Senior high school 1.264 0.374 4.270 0.706 1.054 0.296 3.744 0.936
    College or above 8.133 1.575 41.99 0.012 18.881 4.257 83.755 0.000
Marital status
    Never married 1.000
    Married/cohabitate 0.096 0.024 0.382 0.001 0.121 0.038 0.388 0.000
    Widowed/separated 0.181 0.026 1.267 0.085 0.208 0.037 1.181 0.076
Education*score1
    Junior high school 1.797 0.998 3.236 0.051
    Senior high school 0.822 0.517 1.308 0.408
    College or above 0.294 0.136 0.634 0.002
Sex*score
Female 0.754 0.488 1.164 0.202
Score*age 0.999 0.985 1.014 0.931
Goodness-of-fit (p-value) 0.211 0.921

1Glaucoma knowledge score.

Fig 1A–1C show the marginal effects of education, sex, and their interaction effects at different age intervals. Fig 1A shows the marginal effect of knowledge score by education at each age interval. Knowledge score clearly showed a more positive effect on people with college education or above at all age intervals, and this effect was even more significant with increasing age.

Fig 1. Marginal effects of glaucoma knowledge.

Fig 1

a. Shows the average marginal effect of glaucoma knowledge score by education at various age intervals. b. Shows the average marginal effect of glaucoma knowledge score by sex at various age intervals. c. Shows the effect of glaucoma knowledge by each education/sex stratum. The marginal effects for Fig 1A–1C should be interpreted as the effect on the predicted probability of being in the “High concern group” in percentage points (point estimate × 100).

Fig 1B shows the marginal effect of knowledge score by sex at each age interval. Despite the overall interaction not reaching statistical significance (P = 0.202), for certain age groups, the effect of knowledge showed a clear sex-based disparity. For those in the middle-age groups, women had a clear advantage over men in terms of the effect of knowledge on the outcome variable. Finally, Fig 1C shows the effect of knowledge score by each combination of education and sex at various age intervals. For both men and women, knowledge showed the highest effect for people with the highest level of education. However, women showed a clear advantage over men for people in the highest education group.

Discussions

In this study, we examined self-rated risks for developing glaucoma and evaluated this rating against that rated by the physician. We found a considerable proportion of the subjects in the “High concern” group (approximately 12% in our sample). Attaining reasonable glaucoma knowledge was protective in terms of inaccurate rating; however, this effect only benefited women and those with high education. The unique niche of this study is the fact that it has explored not only the self-evaluated risk, but also discrepancies of such evaluations with professional ratings. Another contribution of this study is that it explores beyond mere glaucoma knowledge; it works through other critical variables, such as education, age, and sex.

Our results should be discussed in light of the study limitations. First, because we could not accurately calculate the response rate, we did not adjust for non-responses in our weighting. Second, it should be noted that the way we formulated the knowledge score assumed that each knowledge question would have equal weights. In addition, various aspects of glaucoma knowledge may be relevant. Despite selecting the knowledge questions carefully based on the literature and expert opinions, it should be noted that conclusion of this study may depend on the choice of the knowledge measurements.

We found that education and glaucoma knowledge score worked independently on accurate ratings in the base model even when controlled for education. Previous studies have rarely distinguished the two parameters, and in cases where education has been investigated, glaucoma-specific education has been emphasized [1518]. We argue that education level per se, rather than education regarding glaucoma knowledge, plays a significant role in the accuracy of risk rating. Few studies have been published on glaucoma and socioeconomic status; the studies that have been published have not reached a consensus; socioeconomically disadvantaged populations have been found to be associated with high or low prevalence levels of glaucoma, depending on the target population and study design [12, 19, 20]. To add to the existing evidence, we found that such socioeconomic disparity may be explained by its interaction effect with glaucoma knowledge. One plausible explanation is that people with high levels of education may be able to utilize knowledge effectively and make appropriate judgments regarding the risks. Significant evidence suggests that people with high socioeconomic status can accurately rate their general health evaluated in terms of a robust objective measure, such as mortality [2123]. However, we also found that the main effect of education follows a reverse trend in favor of the relatively uneducated in both the base and final models. This may suggest that highly educated people with no specific knowledge regarding glaucoma may be overly confident in their health. For example, they are in general more likely to be free of other chronic diseases that are known to have a socioeconomic gradient [24, 25]. By contrast, glaucoma, as mentioned previously, is not associated with a clear socioeconomic gradient.

We also found that the glaucoma knowledge score was associated with a positive effect on reducing the predicted probability of misjudgment. However, the estimates reversed in direction and became non-significant after interaction terms had been added, which has implications both statistically and scientifically. First, the reversal of the estimates from the base model to the full model suggests that disregarding the interactions is not statistically desirable as it leads to reduced model fit. Scientifically, disregarding the interaction terms is associated with misleading results as higher glaucoma knowledge facilitates superior risk assessment that is compatible with conventional wisdom. However, such an effect works with only certain groups of individuals (higher education and female sex in our study).

Age and sex as risk factors have been frequently mentioned in the literature of glaucoma [2628]. Our study adds to the literature by suggesting that knowledge of glaucoma could be one mechanism in addition to the biological characteristics. Allans et al [29] found that women with a known acute coronary syndrome are more likely to perceive the symptoms as not urgent than are men, thus leading to delay in medical treatment. This finding is in agreement with the main effect of sex in our model. However, our study suggests that women, when equipped with reasonable glaucoma knowledge, respond with more accurate risk perceptions. This sex gap can be closed by glaucoma-specific education. This is an expected trend as marginal effects tend to be larger when baseline effect is smaller, as is the case for the women in our study. In terms of age, glaucoma knowledge has a higher protective effect at an older age, stratified by either sex or education. Advanced age is a risk factor for misjudgment, which warrants policy concern as glaucoma is more prevalent at an older age; thus, misjudgment of glaucoma risk at an advanced age is more likely to lead to late presentation. Glaucoma knowledge is positively associated with high age as found in our study. This disparity also can be reduced by emphasizing glaucoma education. However, as our results suggest, such glaucoma-specific education may positively affect those with high education levels and women.

Conclusion

A considerable proportion of patients attending the ophthalmology department underestimate their glaucoma risks. Glaucoma-specific knowledge interacts with education and sex, and thus to reduce disparities in inaccurate glaucoma risk perceptions among various education and sex groups, a higher dosage of glaucoma-specific knowledge must be provided to men and to patients with relatively low education levels.

Supporting information

S1 File. Patient questionnaire (original language).

Questionnaire used in the current study.

(PDF)

S2 File. Patient questionnaire (English).

Questionnaire used in the current study.

(DOCX)

Data Availability

Data cannot be shared publicly because of IRB restrictions by the IRB of National Yang-Ming University. According to the IRB restriction, all individuals who wishes to analyze the data must be specified in the IRB application. Thus, we can not share this dataset online. If a person who was not specified in the IRB application wishes to analyze the data, he/she must obtain approval from the above named IRB. Contact information for ethics committee: email: irb@ym.edu.tw Tel: +886-2-2823-9753.

Funding Statement

This study was supported by Ministry of Science and Technology, Taiwan (Grant number: 109-2314-B-010 -049 -MY2). Grant recipient: C Pu. URL: https://www.most.gov.tw/?l=en The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Grant WM, Burke F Jr. Why do some people go blind from glaucoma? Ophthalmology. 1982;89(9):991–8. doi: 10.1016/s0161-6420(82)34675-8 [DOI] [PubMed] [Google Scholar]
  • 2.Grant WM, Burke JF Jr. Why do some people go blind from glaucoma? Ophthalmology. 1982;89(9):991–8. Epub 1982/09/01. doi: 10.1016/s0161-6420(82)34675-8 . [DOI] [PubMed] [Google Scholar]
  • 3.Susanna R Jr., De Moraes CG, Cioffi GA, Ritch R. Why Do People (Still) Go Blind from Glaucoma? Transl Vis Sci Technol. 2015;4(2):1. Epub 2015/03/15. doi: 10.1167/tvst.4.2.1; PubMed Central PMCID: PMC4354096. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Sommer A, Tielsch JM, Katz J, Quigley HA, Gottsch JD, Javitt J, et al. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans: the Baltimore Eye Survey. Archives of ophthalmology. 1991;109(8):1090–5. doi: 10.1001/archopht.1991.01080080050026 [DOI] [PubMed] [Google Scholar]
  • 5.Shaikh Y, Yu F, Coleman AL. Burden of undetected and untreated glaucoma in the United States. American journal of ophthalmology. 2014;158(6):1121–9. e1. doi: 10.1016/j.ajo.2014.08.023 [DOI] [PubMed] [Google Scholar]
  • 6.Delbaere K, Close JC, Brodaty H, Sachdev P, Lord SR. Determinants of disparities between perceived and physiological risk of falling among elderly people: cohort study. BMJ. 2010;341:c4165. Epub 2010/08/21. doi: 10.1136/bmj.; PubMed Central PMCID: PMC2930273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.McKenney JL, Lapane KL, Assaf AR, Carleton RA. The association between perceived risk and actual cardiovascular disease. Epidemiology. 1995;6(6):612–6. Epub 1995/11/01. doi: 10.1097/00001648-199511000-00009 . [DOI] [PubMed] [Google Scholar]
  • 8.Bovbjerg DH, Keefe FJ, Soo MS, Manculich J, Van Denburg A, Zuley ML, et al. Persistent breast pain in post-surgery breast cancer survivors and women with no history of breast surgery or cancer: associations with pain catastrophizing, perceived breast cancer risk, breast cancer worry, and emotional distress. Acta Oncol. 2019;58(5):763–8. Epub 2019/02/13. doi: 10.1080/0284186X.2019.1574023 ; PubMed Central PMCID: PMC6612426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Higginbotham EJ. How much influence do socioeconomic factors have on glaucoma prevalence and therapeutic outcomes? Arch Ophthalmol. 2006;124(8):1185–6. Epub 2006/08/16. doi: 10.1001/archopht.124.8.1185 . [DOI] [PubMed] [Google Scholar]
  • 10.Fraser S, Bunce C, Wormald R, Brunner E. Deprivation and late presentation of glaucoma: case-control study. Bmj. 2001;322(7287):639–43. doi: 10.1136/bmj.322.7287.639 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Hoevenaars JG, Schouten JS, van den Borne B, Beckers HJ, Webers CA. Socioeconomic differences in glaucoma patients’ knowledge, need for information and expectations of treatments. Acta Ophthalmol Scand. 2006;84(1):84–91. Epub 2006/02/01. doi: 10.1111/j.1600-0420.2005.00587.x . [DOI] [PubMed] [Google Scholar]
  • 12.Oh SA, Ra H, Jee D. Socioeconomic Status and Glaucoma: Associations in High Levels of Income and Education. Curr Eye Res. 2019;44(4):436–41. Epub 2018/11/16. doi: 10.1080/02713683.2018.1548129 . [DOI] [PubMed] [Google Scholar]
  • 13.Valliant R D J. Survey weighrs: A step by step guide to calculation. STATA Press. 2018. [Google Scholar]
  • 14.Heeringa SG, West BT, Berglund PA. Applied survey data analysis: Chapman and Hall/CRC; 2017. [Google Scholar]
  • 15.Aghamollaei H, Nejat F, Jadidi K. Evaluating the Effectiveness of Education in Improving Public Knowledge and Awareness of Glaucoma. J Ophthalmic Vis Res. 2019;14(1):121–2. Epub 2019/03/02. doi: 10.4103/jovr.jovr_55_18 ; PubMed Central PMCID: PMC6388526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Newman-Casey PA, Musser JA, Niziol LM, Heisler MM, Kamat SS, Shah MM, et al. Integrating Patient Education Into the Glaucoma Clinical Encounter: A Lean Analysis. J Glaucoma. 2019;28(5):415–22. Epub 2019/01/15. doi: 10.1097/IJG.0000000000001192 ; PubMed Central PMCID: PMC6499667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Sleath B, Blalock SJ, Carpenter DM, Muir KW, Sayner R, Lawrence S, et al. Provider Education about Glaucoma and Glaucoma Medications during Videotaped Medical Visits. J Ophthalmol. 2014;2014:238939. Epub 2014/05/29. doi: 10.1155/2014/238939; PubMed Central PMCID: PMC4020294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Eldaly M, Hunter M, Khafagy M. The socioeconomic impact among Egyptian glaucoma patients. Br J Ophthalmol. 2007;91(10):1274–5. Epub 2007/09/27. doi: 10.1136/bjo.2006.111757 ; PubMed Central PMCID: PMC2001016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Ko YC, Hwang DK, Chen WT, Lee CC, Liu CJ. Impact of Socioeconomic Status on the Diagnosis of Primary Open-Angle Glaucoma and Primary Angle Closure Glaucoma: A Nationwide Population-Based Study in Taiwan. PLoS One. 2016;11(2):e0149698. Epub 2016/02/26. doi: 10.1371/journal.pone.0149698; PubMed Central PMCID: PMC4764499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Shweikh Y, Ko F, Chan MP, Patel PJ, Muthy Z, Khaw PT, et al. Measures of socioeconomic status and self-reported glaucoma in the U.K. Biobank cohort. Eye (Lond). 2015;29(10):1360–7. Epub 2015/09/01. doi: 10.1038/eye.2015.157 ; PubMed Central PMCID: PMC4815692. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Dowd JB, Zajacova A. Does the predictive power of self-rated health for subsequent mortality risk vary by socioeconomic status in the US? Int J Epidemiol. 2007;36(6):1214–21. Epub 2007/11/01. doi: 10.1093/ije/dym214 . [DOI] [PubMed] [Google Scholar]
  • 22.Lima-Costa MF, Steptoe A, Cesar CC, De Oliveira C, Proietti FA, Marmot M. The influence of socioeconomic status on the predictive power of self-rated health for 6-year mortality in English and Brazilian older adults: the ELSA and Bambui cohort studies. Ann Epidemiol. 2012;22(9):644–8. Epub 2012/07/24. doi: 10.1016/j.annepidem.2012.06.101 . [DOI] [PubMed] [Google Scholar]
  • 23.Suresh S, Sabanayagam C, Shankar A. Socioeconomic status, self-rated health, and mortality in a multiethnic sample of US adults. J Epidemiol. 2011;21(5):337–45. Epub 2011/07/13. doi: 10.2188/jea.JE20100142 ; PubMed Central PMCID: PMC3899432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Addo J, Agyemang C, de-Graft Aikins A, Beune E, Schulze MB, Danquah I, et al. Association between socioeconomic position and the prevalence of type 2 diabetes in Ghanaians in different geographic locations: the RODAM study. J Epidemiol Community Health. 2017;71(7):633–9. Epub 2017/03/30. doi: 10.1136/jech-2016-208322 ; PubMed Central PMCID: PMC5485755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Signorello LB, Schlundt DG, Cohen SS, Steinwandel MD, Buchowski MS, McLaughlin JK, et al. Comparing diabetes prevalence between African Americans and Whites of similar socioeconomic status. Am J Public Health. 2007;97(12):2260–7. Epub 2007/11/01. doi: 10.2105/AJPH.2006.094482 ; PubMed Central PMCID: PMC2089102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Flanagan DW. Diabetes, glaucoma, sex, and cataract. Br J Ophthalmol. 1993;77(1):1. Epub 1993/01/01. doi: 10.1136/bjo.77.1.1; PubMed Central PMCID: PMC504411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Higginbotham EJ. Does sex matter in glaucoma? Arch Ophthalmol. 2004;122(3):374–5. Epub 2004/03/10. doi: 10.1001/archopht.122.3.374 . [DOI] [PubMed] [Google Scholar]
  • 28.Tarkkanen A, Reunanen A, Kivela T. Frequency of age-related macular degeneration among patients with primary chronic open-angle glaucoma and exfoliation glaucoma. Acta Ophthalmol. 2008;86(6):697–8. Epub 2008/06/13. doi: 10.1111/j.1600-0420.2007.01109.x . [DOI] [PubMed] [Google Scholar]
  • 29.Allana S, Moser DDK, Ali DTS, Khan DAH. Sex differences in symptoms experienced, knowledge about symptoms, symptom attribution, and perceived urgency for treatment seeking among acute coronary syndrome patients in Karachi Pakistan. Heart Lung. 2018;47(6):584–90. Epub 2018/08/16. doi: 10.1016/j.hrtlng.2018.06.009 . [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Timo Eppig

30 Jul 2021

PONE-D-21-05901

Accuracy of perceived glaucoma risk by patients in a clinical setting

PLOS ONE

Dear Dr. Pu,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please specify the restrictions that do not allow to make the data available.

Please submit your revised manuscript by Sep 13 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Timo Eppig

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

3. Please include in your Methods section (or in Supplementary Information files) the participating hospitals/institutions.

Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information.

Please provide additional information regarding the participant eligibility criteria used and how participants were recruited for the study. 

4. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. 

5. Please include a copy of Table 1b which you refer to in your text on page 10.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Dear authors,

congratulations to your great work! The data emphazise the impact of education about glaucoma disease in the population.

Only some minor points have to be revised:

table 2: "knowledge"

table 3: "Glaucoma" instead of "galaucoma"

The Figures Legends:

Please describe the figures and their results in more detail in order that the readers will understand the main findings.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Sep 16;16(9):e0257453. doi: 10.1371/journal.pone.0257453.r002

Author response to Decision Letter 0


10 Aug 2021

Dear Editor and Reviewer,

Thank you for the valuable comments on our manuscript. They have indeed helped us enhance our manuscript. We have revised the manuscript based on these comments. All changes are tracked in a different color.

Reviewer #1: Dear authors,

congratulations to your great work! The data emphazise the impact of education about glaucoma disease in the population.

Only some minor points have to be revised:

table 2: "knowledge"

Response: This has been corrected in the revised version

table 3: "Glaucoma" instead of "galaucoma"

Response: Thank you, this has been corrected in the revised version

The Figures Legends:

Please describe the figures and their results in more detail in order that the readers will understand the main findings.

Response: Thank you. More detailed figure legends have been provided in the revised version.

Journal comments:

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Response: Thank you. Formatting has been checked.

2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Response: The reference list has been checked for accuracy.

3. Please include in your Methods section (or in Supplementary Information files) the participating hospitals/institutions.

Response: The hospital name has been added in the revised version.

Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information.

Response: The questionnaire has been included in this submission.

Please provide additional information regarding the participant eligibility criteria used and how participants were recruited for the study.

Response: Details on participant eligibility criteria have been provided in the revised version.

4. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well.

Response: Detailed IRB information has been provided in the revised version.

5. Please include a copy of Table 1b which you refer to in your text on page 10.

Response: Sorry about the typo. It should have been “Figure 1b”.

Attachment

Submitted filename: R1-Response letter.docx

Decision Letter 1

Timo Eppig

2 Sep 2021

Accuracy of perceived glaucoma risk by patients in a clinical setting

PONE-D-21-05901R1

Dear Dr. Pu,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Timo Eppig

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Timo Eppig

8 Sep 2021

PONE-D-21-05901R1

Accuracy of perceived glaucoma risk by patients in a clinical setting

Dear Dr. Pu:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Timo Eppig

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. Patient questionnaire (original language).

    Questionnaire used in the current study.

    (PDF)

    S2 File. Patient questionnaire (English).

    Questionnaire used in the current study.

    (DOCX)

    Attachment

    Submitted filename: R1-Response letter.docx

    Data Availability Statement

    Data cannot be shared publicly because of IRB restrictions by the IRB of National Yang-Ming University. According to the IRB restriction, all individuals who wishes to analyze the data must be specified in the IRB application. Thus, we can not share this dataset online. If a person who was not specified in the IRB application wishes to analyze the data, he/she must obtain approval from the above named IRB. Contact information for ethics committee: email: irb@ym.edu.tw Tel: +886-2-2823-9753.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES